Lv4
730 积分 2022-11-26 加入
Single-cell RNA-seq uncovers cellular heterogeneity and provides a signature for paediatric sleep apnoea
11天前
已完结
Tocilizumab in Active, Moderate-to-Severe, Glucocorticoid-Resistant Thyroid Eye Disease: An Open-Label Prospective Study in Two Independent Cohorts
13天前
已完结
Biglycan knockdown improves Graves’ orbitopathy (GO)-like features via inhibiting NF-kB and ERK signaling
13天前
已完结
In vivo engineering of immunosuppressive T cells to treat ocular autoimmune diseases
14天前
已关闭
Research progress and clinical utility of multi-parameter orbital MRI in thyroid-associated ophthalmopathy
14天前
已完结
Recent advances in management of Graves’ disease: an update
14天前
已关闭
Infographic: teprotumumab for the treatment of active thyroid eye disease
14天前
已完结
Tocilizumab in Active, Moderate-to-Severe, Glucocorticoid-Resistant Thyroid Eye Disease: An Open-Label Prospective Study in Two Independent Cohorts
14天前
已完结
Corticosteroids Versus Teprotumumab for the Treatment of Thyroid Eye Disease. Does Either Mitigate the Need for Additional Treatments?
14天前
已关闭
Corticosteroids Versus Teprotumumab for the Treatment of Thyroid Eye Disease. Does Either Mitigate the Need for Additional Treatments?
14天前
已关闭
皖公网安备34019202002308
